Literature DB >> 15929997

Structural and functional characterization of CFE88: evidence that a conserved and essential bacterial protein is a methyltransferase.

Keith L Constantine1, Stanley R Krystek, Matthew D Healy, Michael L Doyle, Nathan O Siemers, Jane Thanassi, Ning Yan, Dianlin Xie, Valentina Goldfarb, Joseph Yanchunas, Li Tao, Brian A Dougherty, Bennett T Farmer.   

Abstract

CFE88 is a conserved essential gene product from Streptococcus pneumoniae. This 227-residue protein has minimal sequence similarity to proteins of known 3D structure. Sequence alignment models and computational protein threading studies suggest that CFE88 is a methyltransferase. Characterization of the conformation and function of CFE88 has been performed by using several techniques. Backbone atom and limited side-chain atom NMR resonance assignments have been obtained. The data indicate that CFE88 has two domains: an N-terminal domain with 163 residues and a C-terminal domain with 64 residues. The C-terminal domain is primarily helical, while the N-terminal domain has a mixed helical/extended (Rossmann) fold. By aligning the experimentally observed elements of secondary structure, an initial unrefined model of CFE88 has been constructed based on the X-ray structure of ErmC' methyltransferase (Protein Data Bank entry 1QAN). NMR and biophysical studies demonstrate binding of S-adenosyl-L-homocysteine (SAH) to CFE88; these interactions have been localized by NMR to the predicted active site in the N-terminal domain. Mutants that target this predicted active site (H26W, E46R, and E46W) have been constructed and characterized. Overall, our results both indicate that CFE88 is a methyltransferase and further suggest that the methyltransferase activity is essential for bacterial survival.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15929997      PMCID: PMC2253378          DOI: 10.1110/ps.051389605

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  41 in total

1.  Novel inhibitors of Erm methyltransferases from NMR and parallel synthesis.

Authors:  P J Hajduk; J Dinges; J M Schkeryantz; D Janowick; M Kaminski; M Tufano; D J Augeri; A Petros; V Nienaber; P Zhong; R Hammond; M Coen; B Beutel; L Katz; S W Fesik
Journal:  J Med Chem       Date:  1999-09-23       Impact factor: 7.446

2.  Design and synthesis of mimics of S-adenosyl-L-homocysteine as potential inhibitors of erythromycin methyltransferases.

Authors:  S Hanessian; P W Sgarbi
Journal:  Bioorg Med Chem Lett       Date:  2000-03-06       Impact factor: 2.823

3.  High-density miniaturized thermal shift assays as a general strategy for drug discovery.

Authors:  M W Pantoliano; E C Petrella; J D Kwasnoski; V S Lobanov; J Myslik; E Graf; T Carver; E Asel; B A Springer; P Lane; F R Salemme
Journal:  J Biomol Screen       Date:  2001-12

4.  Resistance to macrolides and related antibiotics in Streptococcus pneumoniae.

Authors:  Roland Leclercq; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

5.  Identification of 113 conserved essential genes using a high-throughput gene disruption system in Streptococcus pneumoniae.

Authors:  Jane A Thanassi; Sandra L Hartman-Neumann; Thomas J Dougherty; Brian A Dougherty; Michael J Pucci
Journal:  Nucleic Acids Res       Date:  2002-07-15       Impact factor: 16.971

Review 6.  NMR spectroscopy tools for structure-aided drug design.

Authors:  Steve W Homans
Journal:  Angew Chem Int Ed Engl       Date:  2004-01-03       Impact factor: 15.336

Review 7.  Where will new antibiotics come from?

Authors:  Christopher Walsh
Journal:  Nat Rev Microbiol       Date:  2003-10       Impact factor: 60.633

8.  Mutational analysis defines the roles of conserved amino acid residues in the predicted catalytic pocket of the rRNA:m6A methyltransferase ErmC'.

Authors:  Gordana Maravić; Marcin Feder; Sándor Pongor; Mirna Flögel; Janusz M Bujnicki
Journal:  J Mol Biol       Date:  2003-09-05       Impact factor: 5.469

9.  The gene for a tRNA modifying enzyme, m5U54-methyltransferase, is essential for viability in Escherichia coli.

Authors:  B C Persson; C Gustafsson; D E Berg; G R Björk
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

Review 10.  Utility of homology models in the drug discovery process.

Authors:  Alexander Hillisch; Luis Felipe Pineda; Rolf Hilgenfeld
Journal:  Drug Discov Today       Date:  2004-08-01       Impact factor: 7.851

View more
  2 in total

1.  Crystal structure of Streptococcus pneumoniae Sp1610, a putative tRNA methyltransferase, in complex with S-adenosyl-L-methionine.

Authors:  Hai Minh Ta; Kyeong Kyu Kim
Journal:  Protein Sci       Date:  2010-03       Impact factor: 6.725

2.  Comparative Genomic Analysis of the DUF34 Protein Family Suggests Role as a Metal Ion Chaperone or Insertase.

Authors:  Colbie J Reed; Geoffrey Hutinet; Valérie de Crécy-Lagard
Journal:  Biomolecules       Date:  2021-08-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.